PDSB — PDS Biotechnology Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Annual balance sheet for PDS Biotechnology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	12.2	28.8	65.2	73.8	56.6
Prepaid Expenses
Total Current Assets	14.5	30.3	66.8	76.5	59.1
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.021	0.553	0.358	0.528	0.335
Other Long Term Assets
Total Assets	14.5	30.9	67.2	77	59.4
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	2.79	3.27	3.76	9.82	13.6
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	2.79	3.76	3.99	33	33.3
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	11.7	27.1	63.2	44	26.1
Total Liabilities & Shareholders' Equity	14.5	30.9	67.2	77	59.4
Total Common Shares Outstanding